[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crescent Biopharma Inc (CBIO)

Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Crescent Biopharma Inc 300 FIFTH AVENUE WALTHAM MA 02451 USA

www.crescentbiopharma.com Employees: 44 P: 617-430-5595

Sector:

Medical

Description:

Crescent Biopharma is a biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients with solid tumors. Crescent Biopharma, formerly known as GlycoMimetics Inc., is based in ROCKVILLE, Md.

Key Statistics

Overview:

Market Capitalization, $K 407,017
Enterprise Value, $K 197,827
Shares Outstanding, K 27,557
Float, K 20,712
% Float 75.16%
Short Interest, K 3,743
Short Float 13.58%
Days to Cover 9.73
Short Volume Ratio 0.50
% of Insider Shareholders 24.84%
% of Institutional Shareholders 75.19%

Financials:

Annual Sales, $ 10,840 K
Annual Net Income, $ -153,940 K
Last Quarter Sales, $ 1,040 K
Last Quarter Net Income, $ -23,280 K
EBIT, $ -185,810 K
EBITDA, $ -185,730 K

Growth:

1-Year Return 19.21%
3-Year Return -90.77%
5-Year Return -92.83%
5-Year Revenue Growth 6.69%
5-Year Earnings Growth 88.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.70 on 04/29/26
Next Earnings Date 07/30/26 [--]
Earnings Per Share ttm -10.91
EPS Growth vs. Prev Qtr 82.54%
EPS Growth vs. Prev Year 82.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 08/20/15
Dividend Payable Date 08/19/15
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 06/16/25

CBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -103.44%
Return-on-Assets % -88.19%
Profit Margin % -1,420.11%
Debt/Equity 0.00
Price/Sales 41.78
Price/Cash Flow N/A
Price/Book 2.52
Book Value/Share 6.67
Interest Coverage -68.38
60-Month Beta 1.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.